PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
September 1, 2011 | ISSUE NUMBER 215 VOL 8


Digital
Pharma Failing to eMarket Effectively
Consumers and healthcare practitioners have come to rely on digital platforms for medical advice, but as Google trumps nurses, pharmacists, friends and family as the second most-frequently-named influencer of health decisions, pharmaceutical companies are disproportionately silent in the digital space
...Read More

Europe
EU Wrestles with Outdated Clinical Research Rules
The European Union has received 143 responses to a recent consultation on how it should update its clinical trials rules – with hospitals, investigators and non-commercial or academic sponsors the loudest in raising their voices. But not everyone favors radical reform ...Read More

Emering Pharma Leaders
Leadership in a Lean Market
Can ‘lean management’, as opposed to products, be a driver of innovation, particularly on the neglected side of business processes? Pharm Exec’s 2011 Emerging Pharma Leaders give their views in these exclusive podcasts
...Listen now

Drug Safety
Shortages Encourage Gray Market Activity
So-called gray market distributors, unofficial sellers are now taking advantage of drug shortages to resell scarce products at inflated prices ...Read More

// Jonathon Singer joined Sagent Pharmaceuticals (Schaumberg, Ill) as Chief Financial Officer. // Oncology drug company Celsion (Columbia, MD) appointed Gary Renshaw as Executive Medical Director. // Yourway Transport, Inc. (Allentown, Penn.) announced the appointment of Tim Brewer as President of its newly launched BioPharma Services division. // Gordana Kosutic, MD, resigned as Vice President, Clinical and Regulatory Affairs of Tranzyme Pharma (Research Triangle Park, NC). M. Scott Harris, MD, will take over the role on an interim basis.

Sept. 20–21: Strategic Pipeline Planning and Resource Allocation Summit
Philadelphia, PA

Sept. 26–27: Pharma/Bio Forum on Preclinical Development
Boston, MA


Sept. 26–27: Prix Galien: 'Pharma's Proudest Night'
New York, NY


Sept. 27–28: Planning Your Drug Development Success—From Bench to Clinic Research
Triangle Park, NC, and Philadelphia, PA


Oct. 14: L2 Clinic: The Social Graph: Pharma
New York, NY


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook



Survey
How many conferences will you be attending during the remainder of this year?
Click To Vote
 
Quick Links

Google's Worldwide Woes

Reducing the Risk in Risk Management

UK 'Sabotage' Scare


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive